> top > docs > PubMed:32830267 > annotations

PubMed:32830267 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 105-110 Body_part denotes Bowel http://purl.org/sig/ont/fma/fma7199
T2 251-256 Body_part denotes bowel http://purl.org/sig/ont/fma/fma7199

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 54-62 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T2 65-74 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T3 92-118 Disease denotes Inflammatory Bowel Disease http://purl.obolibrary.org/obo/MONDO_0005265
T4 200-208 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T5 211-220 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T6 238-264 Disease denotes inflammatory bowel disease http://purl.obolibrary.org/obo/MONDO_0005265
T7 266-269 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T9 349-357 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T10 360-369 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T11 387-390 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T13 500-503 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T15 564-572 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 575-584 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T17 767-770 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T19 924-933 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T20 1029-1042 Disease denotes Crohn disease http://purl.obolibrary.org/obo/MONDO_0005011|http://purl.obolibrary.org/obo/MONDO_0009960
T22 1044-1046 Disease denotes CD http://purl.obolibrary.org/obo/MONDO_0005011
T23 1140-1148 Disease denotes diarrhea http://purl.obolibrary.org/obo/MONDO_0001673
T24 1215-1218 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T26 1235-1243 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T27 1246-1255 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T28 1317-1320 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T30 1342-1350 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 1519-1528 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T32 1736-1744 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T33 1747-1756 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T34 1774-1777 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T36 1832-1841 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T37 1855-1858 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265
T39 1949-1957 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T40 1963-1971 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T41 1974-1984 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T42 2016-2019 Disease denotes IBD http://purl.obolibrary.org/obo/MONDO_0005052|http://purl.obolibrary.org/obo/MONDO_0005265

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 120-121 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T2 276-279 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T3 409-410 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 613-625 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T5 983-989 http://purl.obolibrary.org/obo/UBERON_0003100 denotes female
T6 1114-1116 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T7 1650-1651 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T8 1818-1819 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1927-1928 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1044-1046 Chemical denotes CD http://purl.obolibrary.org/obo/CHEBI_8673
T2 1870-1886 Chemical denotes immunomodulators http://purl.obolibrary.org/obo/CHEBI_50846

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-119 Sentence denotes Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease:
T2 120-159 Sentence denotes A Single-Center Study in Madrid, Spain.
T3 160-171 Sentence denotes BACKGROUND:
T4 172-271 Sentence denotes There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD).
T5 272-391 Sentence denotes Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD.
T6 392-400 Sentence denotes METHODS:
T7 401-448 Sentence denotes This is a cross-sectional, observational study.
T8 449-642 Sentence denotes We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition.
T9 643-725 Sentence denotes Data were obtained by patient electronical medical records and by phone interview.
T10 726-734 Sentence denotes RESULTS:
T11 735-934 Sentence denotes Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection.
T12 935-1077 Sentence denotes Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities.
T13 1078-1176 Sentence denotes Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%).
T14 1177-1256 Sentence denotes One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection.
T15 1257-1351 Sentence denotes Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19.
T16 1352-1425 Sentence denotes Most of the patients had mild disease (79.3%), and 1 patient died (1.2%).
T17 1426-1675 Sentence denotes In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course.
T18 1676-1722 Sentence denotes Immunosuppression was not related to severity.
T19 1723-1790 Sentence denotes CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare.
T20 1791-1842 Sentence denotes Dyspnea is associated with a more severe infection.
T21 1843-2030 Sentence denotes Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups.
T1 0-119 Sentence denotes Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease:
T2 120-159 Sentence denotes A Single-Center Study in Madrid, Spain.
T3 160-171 Sentence denotes BACKGROUND:
T4 172-271 Sentence denotes There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD).
T5 272-391 Sentence denotes Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD.
T6 392-400 Sentence denotes METHODS:
T7 401-448 Sentence denotes This is a cross-sectional, observational study.
T8 449-642 Sentence denotes We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition.
T9 643-725 Sentence denotes Data were obtained by patient electronical medical records and by phone interview.
T10 726-734 Sentence denotes RESULTS:
T11 735-934 Sentence denotes Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection.
T12 935-1077 Sentence denotes Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities.
T13 1078-1176 Sentence denotes Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%).
T14 1177-1256 Sentence denotes One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection.
T15 1257-1351 Sentence denotes Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19.
T16 1352-1425 Sentence denotes Most of the patients had mild disease (79.3%), and 1 patient died (1.2%).
T17 1426-1675 Sentence denotes In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course.
T18 1676-1722 Sentence denotes Immunosuppression was not related to severity.
T19 1723-1790 Sentence denotes CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare.
T20 1791-1842 Sentence denotes Dyspnea is associated with a more severe infection.
T21 1843-2030 Sentence denotes Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 92-118 Phenotype denotes Inflammatory Bowel Disease http://purl.obolibrary.org/obo/HP_0002037
T2 238-264 Phenotype denotes inflammatory bowel disease http://purl.obolibrary.org/obo/HP_0002037
T3 266-269 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T4 337-369 Phenotype denotes severity of SARS-CoV-2 infection http://purl.obolibrary.org/obo/HP_0033141
T5 387-390 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T6 500-503 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T7 767-770 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T8 1029-1042 Phenotype denotes Crohn disease http://purl.obolibrary.org/obo/HP_0100280
T9 1044-1046 Phenotype denotes CD http://purl.obolibrary.org/obo/HP_0100280
T10 1140-1148 Phenotype denotes diarrhea http://purl.obolibrary.org/obo/HP_0002014
T11 1215-1218 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T12 1317-1320 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T13 1472-1479 Phenotype denotes dyspnea http://purl.obolibrary.org/obo/HP_0002094
T14 1512-1528 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T15 1579-1587 Phenotype denotes myalgias http://purl.obolibrary.org/obo/HP_0003326
T16 1774-1777 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T17 1791-1798 Phenotype denotes Dyspnea http://purl.obolibrary.org/obo/HP_0002094
T18 1825-1841 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T19 1855-1858 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T20 2016-2019 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-119 Sentence denotes Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease:
T2 120-159 Sentence denotes A Single-Center Study in Madrid, Spain.
T3 160-171 Sentence denotes BACKGROUND:
T4 172-271 Sentence denotes There are scarce data about SARS-CoV-2 infection in patients with inflammatory bowel disease (IBD).
T5 272-391 Sentence denotes Our aim was to analyze the incidence, clinical presentation, and severity of SARS-CoV-2 infection in patients with IBD.
T6 392-400 Sentence denotes METHODS:
T7 401-448 Sentence denotes This is a cross-sectional, observational study.
T8 449-642 Sentence denotes We contacted all the patients being treated at our IBD unit to identify those patients with suspected or confirmed SARS-CoV-2 infection, following the World Health Organization case definition.
T9 643-725 Sentence denotes Data were obtained by patient electronical medical records and by phone interview.
T10 726-734 Sentence denotes RESULTS:
T11 735-934 Sentence denotes Eighty-two of 805 patients with IBD (10.2%; 95% confidence interval [CI], 8.3-12.5) were diagnosed as having confirmed (28 patients, 3.5%; 95% CI, 2.4-5.0) or suspected (54 patients, 6.7%) infection.
T12 935-1077 Sentence denotes Patient age was 46 ± 14 years, 44 patients were female (53.7%), 17.3% were smokers, 51.2% had Crohn disease (CD), and 39.0% had comorbidities.
T13 1078-1176 Sentence denotes Digestive symptoms were reported in 41 patients (50.0%), with diarrhea as the most common (42.7%).
T14 1177-1256 Sentence denotes One patient (1.2%) was diagnosed with IBD flare-up during SARS-CoV-2 infection.
T15 1257-1351 Sentence denotes Twenty-two patients (26.8%) temporarily withdrew from their IBD treatment because of COVID-19.
T16 1352-1425 Sentence denotes Most of the patients had mild disease (79.3%), and 1 patient died (1.2%).
T17 1426-1675 Sentence denotes In the multivariate analysis, the presence of dyspnea was associated with moderate to severe infection (odds ratio, 5.3; 95% CI, 1.6-17.7; P = 0.01) and myalgias (odds ratio, 4.8; 95% CI, 1.3-17.9; P = 0.02) were related to a milder clinical course.
T18 1676-1722 Sentence denotes Immunosuppression was not related to severity.
T19 1723-1790 Sentence denotes CONCLUSIONS: SARS-CoV-2 infection in patients with IBD is not rare.
T20 1791-1842 Sentence denotes Dyspnea is associated with a more severe infection.
T21 1843-2030 Sentence denotes Therapy for IBD, including immunomodulators and biologic therapy, is not related to a greater severity of COVID-19, and SARS-CoV-2 infections do not appear to be related to IBD flare-ups.

hydroxychloroquine

Id Subject Object Predicate Lexical cue hp_id
T1 92-118 Phenotype denotes Inflammatory Bowel Disease http://purl.obolibrary.org/obo/HP_0002037
T2 238-264 Phenotype denotes inflammatory bowel disease http://purl.obolibrary.org/obo/HP_0002037
T3 266-269 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T4 337-369 Phenotype denotes severity of SARS-CoV-2 infection http://purl.obolibrary.org/obo/HP_0033141
T5 387-390 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T6 500-503 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T7 767-770 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T8 1029-1042 Phenotype denotes Crohn disease http://purl.obolibrary.org/obo/HP_0100280
T9 1044-1046 Phenotype denotes CD http://purl.obolibrary.org/obo/HP_0100280
T10 1140-1148 Phenotype denotes diarrhea http://purl.obolibrary.org/obo/HP_0002014
T11 1215-1218 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T12 1317-1320 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T13 1472-1479 Phenotype denotes dyspnea http://purl.obolibrary.org/obo/HP_0002094
T14 1512-1528 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T15 1579-1587 Phenotype denotes myalgias http://purl.obolibrary.org/obo/HP_0003326
T16 1774-1777 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T17 1791-1798 Phenotype denotes Dyspnea http://purl.obolibrary.org/obo/HP_0002094
T18 1825-1841 Phenotype denotes severe infection http://purl.obolibrary.org/obo/HP_0032169
T19 1855-1858 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037
T20 2016-2019 Phenotype denotes IBD http://purl.obolibrary.org/obo/HP_0002037